These success, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 guidance the concept of targeting ACKR3 as a novel technique to modulate the opioid process, which could open new therapeutic avenues for opioid-connected disorders. These effects recommend that conolidine is https://johnw445wkt9.wannawiki.com/user